Pediatrix Medical Group, Inc. (MD) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Lifestance Health Group, Inc.

Azenta, Inc.

Addus HomeCare Corp.

Pediatrix Medical Group, Inc.

NeoGenomics, Inc.

U.S. Physical Therapy, Inc.

RadNet, Inc.

Ginkgo Bioworks Holdings, Inc.

Hims & Hers Health, Inc.

OPKO Health, Inc.

Celldex Therapeutics, Inc.

Why is Pediatrix Medical Group, Inc. ?

With a growth in Net Profit of 89.32%, the company declared Very Positive results in Jun 25

OPERATING CASH FLOW(Y) Highest at USD 244.56 MM
ROCE(HY) Highest at 14.27%
INTEREST COVERAGE RATIO(Q) Highest at 755.9

With ROCE of 16.57%, it has a risky valuation with a 1.35 Enterprise value to Capital Employed

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 55.70%, its profits have risen by 44.5% ; the PEG ratio of the company is 0.2

Market Beating Performance

The stock has generated a return of 55.70% in the last 1 year, much higher than market (S&P 500) returns of 14.11%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Pediatrix Medical Group, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Pediatrix Medical Group, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Pediatrix Medical Group, Inc.

77.91%

4.31

51.03%

S&P 500

22.24%

0.70

20.15%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-3.03%

EBIT Growth (5y)

3.94%

EBIT to Interest (avg)

3.79

Debt to EBITDA (avg)

2.77

Net Debt to Equity (avg)

0.51

Sales to Capital Employed (avg)

1.35

Tax Ratio

1.59%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

13.11%

ROE (avg)

14.52%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.97

EV to EBIT

7.83

EV to EBITDA

7.15

EV to Capital Employed

1.86

EV to Sales

0.95

PEG Ratio

0.26

Dividend Yield

ROCE (Latest)

23.74%

ROE (Latest)

21.04%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD 258.7 MM

ROCE(HY)

Highest at 20.89%

DEBTORS TURNOVER RATIO(HY)

Highest at 7.89 times

RAW MATERIAL COST(Y)

Fallen by -5.98% (YoY

-2What is not working for the Company

PRE-TAX PROFIT(Q)

At USD 43.77 MM has Fallen at -26.66%

NET PROFIT(Q)

At USD 33.32 MM has Fallen at -26.86%

Here's what is working for Pediatrix Medical Group, Inc.

Operating Cash Flow

Highest at USD 258.7 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debtors Turnover Ratio

Highest at 7.89 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -5.98% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at USD 6.12 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Pediatrix Medical Group, Inc.

Pre-Tax Profit

At USD 43.77 MM has Fallen at -26.66%

over average net sales of the previous four periods of USD 59.68 MM

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit

At USD 33.32 MM has Fallen at -26.86%

over average net sales of the previous four periods of USD 45.55 MM

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)